“Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s102, https://doi.org/10.25251/skin.6.supp.102.